Mark Coleman, Director: Axsome Therapeutics AXSM Sell · Filed 02/27

Trade details

Type: Insider sale
Amount: $4,027,750
Shares · price: 25,000 sh · $161.11 a share
Held after: 47,140 sh
Stock: Axsome Therapeutics AXSM
Person: Mark ColemanDirector
Trade date: 26/02/26
Filed: 26/02/27
Days to filing: 1 days

Sold 34.7% of holdings

Share of holding sold: 34.7%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 01/27~03/28

Mark Coleman's recent trades

Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 05/29
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 06/01
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.2M
5,537 sh
$1.2M
Filed 06/02
Traded 06/02

Mark Coleman, Director — sold $4M of Axsome Therapeutics AXSM · 34.7% of holdings · 10b5-1 plan | Whalegun